Francis Cuss Net Worth & Insider Trades

Francis Cuss - Director, Rubius Therapeutics, Inc

As of May 13, 2022

What is Francis Cuss's Net Worth?

The current estimated net worth of Rubius Therapeutics, Inc's Director, Francis Cuss, is estimated to be about $36.08M . Francis Cuss owns about 10,000 units of Rubius Therapeutics, Inc common stock. In the last 4 years at Rubius Therapeutics, Inc, Francis Cuss has sold an estimated value of $0 worth.

What is Francis Cuss's Past Insider Trading?

Francis Cuss's largest purchase order was 10,000 units , worth over $230K on July 23, 2018. In total, Francis Cuss has made about 6 transactions over 4 years of their time at Rubius Therapeutics, Inc. Francis Cuss usually trades in May, with the busiest year in 2018.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Francis Cuss's' Mailing Address?

  • Mailing address is Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton NJ 08543 NJ

What are Rubius Therapeutics, Inc's Past Insider Trades?

Rubius Therapeutics, Inc's most recent insider trade came on February 27, 2023 by Dannielle Appelhans who sold 10,385 units worth $1.32K . In the last 5 years, insiders at Rubius Therapeutics, Inc have sold an estimated value of $5.74M and bought an estimated value of $8.17M worth of shares. Insider trading is most common in May, with the busiest year in 2019. The most active traders at the company are David Epstein, Director,  Pablo Cagnoni, Director,  and Christopher Carpenter, Chief Medical Officer .

Rubius Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...